Screening for New Primary Cancers in Patients with Metastatic Breast Cancer: A Provincial Analysis of the Choosing Wisely Canada Recommendations

• DOI: 10.3747/co.26.4289
• Publication Date: 2019-07-24T16:55:14Z
• Authors: M. Tesch; K. Laing
• Keywords: Sigmoidoscopy; Cancer screening

Patients with metastatic cancer have a decreased life expectancy, and screening surveillance for new primary cancers, they run the risk of immediate harm little chance any benefit. Choosing Wisely Canada therefore recommends that such investigations be avoided in patients disease.We examined practices subset Newfoundland Labrador. breast seen at provincial clinic during 2014-2016 were identified from Labrador Cancer Registry. For each patient, we assessed whether one or combination mammography, Pap (Papanicolaou) test, flexible sigmoidoscopy colonoscopy, fecal immunohistochemical test performed point after diagnosis disease.Of 305 cancer, 114 (37.4%) underwent least 1 investigation (mean: 2.92 per screened patient). The most common mammography (n = 197) 107). Primary care providers ordered (70%); oncology specialists 14%, other specialists, 12%. Median overall survival disease was 42 months, 5-year 35.9%.A significant proportion are still undergoing malignancies, which is discordant guidelines Canada. Increased education strategies needed if recommendations to implemented into routine clinical practice.